XENOMAX
associated with 23 other trademarks
Pharmaceuticals, namely, antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune disease...

Words that describe this trademark:

therapeutic treatment  clinical diagnostic  autoimmune diseases  treatment cancer  thereof  cancer  diagnostic  pharmaceuticals  antibodies  fragments 

Serial Number:

78526189

Mark:

XENOMAX

Status:

Abandoned-After Publication

Status Date:

11-15-2007

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals, namely, antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

06-12-2007

Mark Drawing Status:

Standart Character Mark

Abandon Date:

11-14-2007

Business Name:

DLA PIPER US LLP

Recent Trademark filings by this company